Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

14 Results
Document type : Journal articles
Document type : Conference papers
Document type : Conference poster
Document type : Books
Document type : Book sections
Document type : Directions of work or proceedings
Document type : Patents
Document type : Other publications
authFullName_s : Hervé Avet-Loiseau
Image document

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Niccolò Bolli , Yan-Fu Li , S Sathiaseelan , Keiran Martin Raine , Wendy D Jones , et al.
Blood Cancer Journal, 2016, 6 ((9)), pp.e467. ⟨10.1038/bcj.2016.72⟩
Journal articles inserm-01382540v1
Image document

The dChip survival analysis module for microarray data.

Samir Amin , Parantu Shah , Aimin Yan , Sophia Adamia , Stéphane Minvielle , et al.
BMC Bioinformatics, 2011, 12 (1), pp.72. ⟨10.1186/1471-2105-12-72⟩
Journal articles inserm-00622802v1

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Philippe Moreau , Frédéric Garban , Michel Attal , Mauricette Michallet , Gérald Marit , et al.
Blood, 2008, 112 (9), pp.3914-5. ⟨10.1182/blood-2008-07-168823⟩
Journal articles hal-00821148v1
Image document

Deciphering the chronology of copy number alterations in Multiple Myeloma

Anil Aktas Samur , Stephane Minvielle , Masood Shammas , Mariateresa Fulciniti , Florence Magrangeas , et al.
Blood Cancer Journal, 2019, 9 (4), pp.39. ⟨10.1038/s41408-019-0199-3⟩
Journal articles inserm-02290251v1

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

Hervé Avet-Loiseau , Cyrille Hulin , Loic Campion , Philippe Rodon , Gerald Marit , et al.
Journal of Clinical Oncology, 2013, 31 (22), pp.2806--2809. ⟨10.1200/JCO.2012.46.2598⟩
Journal articles hal-01064339v1
Image document

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün , Mehmet Kemal Samur , Kristen B Cowens , Steven Paula , Giada Bianchi , et al.
Clinical Cancer Research, 2015, 21, pp.4607 - 4625. ⟨10.1158/1078-0432.CCR-15-0200⟩
Journal articles inserm-02536335v1
Image document

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome

Bruno Royer , Stéphane Minvielle , Momar Diouf , Murielle Roussel , Lionel Karlin , et al.
Journal of Clinical Oncology, 2016, 34 (18), pp.2125 - 2132. ⟨10.1200/JCO.2015.63.1929⟩
Journal articles inserm-01822878v1
Image document

Bortezomib-doxorubicin-cyclophosphamide-dexamethasone induction followed by stem cell transplantation for primary plasma cell leukemia: a prospective phase II study of the IFM

Bruno Royer , Minvielle Stéphane , Momar Diouf , Murielle Roussel , Lionel Karlin , et al.
Journal of Clinical Oncology, 2016, 34 (18), pp.2125-2132. ⟨10.1200/JCO.2015.63.1929⟩
Journal articles inserm-01273359v1
Image document

A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients

Florence Magrangeas , Rowan Kuiper , Hervé Avet-Loiseau , Wilfried Gouraud , Catherine Guérin-Charbonnel , et al.
Clinical Cancer Research, 2016, Epub ahead of print. ⟨10.1158/1078-0432.CCR-15-3163⟩
Journal articles inserm-01313506v1

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu , Michel Attal , Bertrand Arnulf , Philippe Moreau , Catherine Traulle , et al.
Blood, 2013, 121 (11), pp.1968--1975. ⟨10.1182/blood-2012-09-452375⟩
Journal articles hal-01064417v1
Image document

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

Mohamed Amine Hamouda , Arnaud Jacquel , Guillaume Robert , Alexandre Puissant , Valentine Richez , et al.
Journal of Experimental Medicine, 2016, [Epub ahead of print]. ⟨10.1084/jem.20150983⟩
Journal articles inserm-01353362v1
Image document

The shaping and functional consequences of the dosage effect landscape in multiple myeloma.

Mehmet Samur , Parantu Shah , Xujun Wang , Stéphane Minvielle , Florence Magrangeas , et al.
BMC Genomics, 2013, 14 (1), pp.672. ⟨10.1186/1471-2164-14-672⟩
Journal articles inserm-00903866v1

Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Michel Attal , Valerie Lauwers-Cances , Gerald Marit , Denis Caillot , Philippe Moreau , et al.
New England Journal of Medicine, 2012, 366 (19), pp.1782-91. ⟨10.1056/NEJMoa1114138⟩
Journal articles hal-00852275v1
Image document

ABT-737 is highly effective against molecular subgroups of multiple myeloma

Linda Bodet , Patricia Gomez-Bougie , Cyrille Touzeau , Christelle Dousset , Géraldine Descamps , et al.
Blood, 2011, 118 (14), pp.3901 - 3910. ⟨10.1182/blood-2010-11-317438⟩
Journal articles inserm-03290338v1